TrialThe Journal of international medical research2020

Pre-infusion single-dose mesenchymal stem cells promote platelet engraftment and decrease severe acute graft versus host disease without relapse in haploidentical peripheral blood stem cell transplantation.

Xiaoning Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.